RxDoctor Payments Data

Ruby Ward

Psychiatric/Mental Health · Ferriday, LANPI 1750335782

Payments from drug & device makers

$1,978in general payments, 2019–2025

Across 111 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$457
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$368
  • Axsome Therapeutics, Inc.$271
  • Otsuka America Pharmaceutical, Inc.$268
  • Alkermes, Inc.$160
  • Lundbeck LLC$122
  • plus $331 from 8 others

What the payments were for

  • Food & beverage$1,93198%
  • Education$472%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,978 in reported general payments places this provider in the 60th percentile of 615 psychiatric/mental health providers in Louisiana.

See all psychiatric/mental health providers in Louisiana

Medicare billing

Part B allowed, 2024
$457
Medicare patients
19
Services billed
30

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl31$47,180
CaplytaLumateperone Tosylate15$23,399
NuedextaDextromethorphan Hbr/Quinidine11$16,498
Aripiprazole74$2,881
Sertraline Hcl164$1,474
Ziprasidone Hcl47$1,412
Divalproex Sodium63$1,253
Oxcarbazepine32$1,251
Haloperidol Decanoate26$1,106
Bupropion XlBupropion Hcl70$1,048
Benztropine Mesylate89$1,031
Chlorpromazine Hcl13$997
Escitalopram Oxalate106$899
Lurasidone Hcl26$735
Venlafaxine Hcl ErVenlafaxine Hcl57$702

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$457$47,18031 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$368$23,39915 claims
Avanir Pharmaceuticals, Inc.Nuedexta$40$16,49811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 615 psychiatric/mental health providers in Louisiana.

Other psychiatric/mental health in Ferriday

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →